Effect of cyclodextrin complexation on the photostability of promazine in aqueous solution

Pharmazie

Volumn 54, Issue 7, 1999, Pages 549-550

  Lutka, Anna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN; GAMMA CYCLODEXTRIN; HEPTAKIS(2,3,6 O TRIMETHYL) BETA CYCLODEXTRIN; HEPTAKIS(2,6 O DIMETHYL) BETA CYCLODEXTRIN; PROMAZINE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; HYDROGEN BOND; LIGHT ABSORPTION; PHOTODEGRADATION; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROPHOTOMETRY;

EID: 0032782349     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tarasiewicz, M.; Wolyniec, E.; Puzanowska-Tarasiewicz, H.: Pharmazie 53, 151 (1998)
2. Misiuk, W.; Tarasiewicz, M.: Acta Polon. Pharm.-Drug Res. 54, 115 (1997)
3. Lutka, A.: Pharmazie, in press
4. Roseboom, H.; Fresen, J. A.: Pharm. Acta Helv. 50, 55 (1975)
5. Duchêne, D.; Wouessidjewe, D.: Acta Pharm. Technol. 36, 1 (1990)
6. Grimm, W.; Krummen, K.: Stability Testing in the EC, Japan and the USA - Scientific and Regulatory Requirements, p. 225, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 1993
7. Singh, U. V.; Aital, K. S.; Udupa, N.: Pharmazie 53, 208 (1998)
8. Lutka, A.; Pawlaczyk, J.: Acta Polon. Pharm.-Drug. Res. 54, 279 (1997)
9. Mielcarek, J.: J. Pharm. Biomed. Anal. 15, 681 (1997)
10. Mielcarek, J.: Drug. Dev. Ind. Pharm. 24, 197 (1998)
11. McCandless, R.; Yalkowsky, S. H.: J. Pharm. Sci. 87, 1639 (1998)
12. Otagiri, M.; Uekama, K.; Ikeda, K.: Chem. Pharm. Bull. 23, 188 (1975)